Kestra Medical Technologies, Ltd. Common Stock KMTS Ratios & Valuation
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 48.8%+2.4pp | 46.4%+2.9pp | 43.5%+3.0pp | 40.5%+6.8pp | 33.6%+9.0pp | |
| Operating margin | -171.5%+2.8pp | -174.3%+1.6pp | -175.9%+1.9pp | -177.8%-17.5pp | -160.4%+33.1pp | |
| Net margin | -173%+5.0pp | -178%+2.4pp | -180.3%+9.9pp | -190.3%-18.1pp | -172.2%+38.7pp | |
| EBITDA margin | -161.7%+1.7pp | -163.4%+1.1pp | -164.5%+0.1pp | -164.5%-22.4pp | -142.1%+27.1pp | |
| Free cash flow margin | -142.9%+10.0pp | -152.9%+13.4pp | -166.3%+1.8pp | -168.1%+14.0pp | -182.1%+33.5pp | |
| Liquidity | ||||||
| Current ratio | 7.3×+1.9× | 5.5×-1.4× | 6.8×+0.1× | 6.7×— | —— | |
| Quick ratio | 7.3×+1.9× | 5.5×-1.4× | 6.8×+0.1× | 6.7×— | —— | |
| Cash ratio | 6.8×+1.9× | 4.9×-1.3× | 6.2×0.0× | 6.3×— | —— | |
| Leverage | ||||||
| Debt-to-assets | 0.1×-0.1× | 0.2×0.0× | 0.2×0.0× | 0.1×— | —— | |
| Interest coverage | -19.2×-1.7× | -17.6×-2.6× | -15×-1.3× | -13.8×-3.2× | -10.5×+0.4× | |
| Valuation | ||||||
| Market capitalization | $1.29B+70.8% | $1.41B+66.3% | $847.25M— | —— | —— | |
| Enterprise value | $1.04B— | $1.28B+85.1% | $690.63M— | —— | —— | |
| Price / sales | 15.4×— | 19×+6.2× | 12.8×— | —— | —— | |
| EV / sales | 12.8×— | 17.2×+6.8× | 10.4×— | —— | —— | |
| Free cash flow yield | -9.1%— | -8.1%+5.0pp | -13%— | —— | —— | |
| Earnings yield | -11%— | -9.4%+4.8pp | -14.1%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) runs a 48.8% gross margin and a -171.5% operating margin, with a -173.0% net margin.
- Where do Kestra Medical Technologies, Ltd. Common Stock's ratios come from?
- Every ratio is computed from Kestra Medical Technologies, Ltd. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
